BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8683538)

  • 21. Dienes typing of Proteus strains isolated from barrier-maintained animals.
    Simpson W; Simmons DJ
    Lab Anim; 1976 Oct; 10(10):413-7. PubMed ID: 790014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Detection of bacteriocin production by Proteus mirabilis. Proposal for a new protocol for bacteriocin typing].
    Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández Crehuet M; Cueto Espinar A; Piédrola Angulo G
    Rev Latinoam Microbiol; 1984; 26(4):299-303. PubMed ID: 6395246
    [No Abstract]   [Full Text] [Related]  

  • 23. Urease-positive bacteriuria and obstruction of long-term urinary catheters.
    Mobley HL; Warren JW
    J Clin Microbiol; 1987 Nov; 25(11):2216-7. PubMed ID: 3320089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epidemiological application of a new bacteriocin typing procedure for Proteus mirabilis].
    Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández-Crehuet M; Gálvez Vargas R; Piédrola Angulo G
    Rev Latinoam Microbiol; 1985; 27(1):7-10. PubMed ID: 3892620
    [No Abstract]   [Full Text] [Related]  

  • 25. The ability of a Proteus mirabilis strain to invade the bloodstream is independent of its proticine production/proticine sensitivity type.
    Senior BW
    J Med Microbiol; 1997 May; 46(5):407-12. PubMed ID: 9152037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A highly discriminatory multi-typing scheme for Proteus mirabilis and Proteus vulgaris.
    Senior BW; Larsson P
    J Med Microbiol; 1983 May; 16(2):193-202. PubMed ID: 6188832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preputial condition and urinary tract infections.
    Kim KK
    J Korean Med Sci; 1996 Aug; 11(4):332-4. PubMed ID: 8878802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.
    Khan AU; Musharraf A
    Med Sci Monit; 2004 Nov; 10(11):CR598-602. PubMed ID: 15507850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources.
    Mobley HL; Chippendale GR
    J Infect Dis; 1990 Mar; 161(3):525-30. PubMed ID: 2179424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial pathogens associated with urinary tract infections.
    Ling GV; Biberstein EL; Hirsh DC
    Vet Clin North Am Small Anim Pract; 1980 Nov; 9(4):617-30. PubMed ID: 6996293
    [No Abstract]   [Full Text] [Related]  

  • 31. Survey of multidrug resistance integrative mobilizable elements SGI1 and PGI1 in Proteus mirabilis in humans and dogs in France, 2010-13.
    Schultz E; Haenni M; Mereghetti L; Siebor E; Neuwirth C; Madec JY; Cloeckaert A; Doublet B
    J Antimicrob Chemother; 2015 Sep; 70(9):2543-6. PubMed ID: 26066582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of hospital strains of Proteus mirabilis by the methods of proticine and bacteriophage typing].
    Zawieja M
    Med Dosw Mikrobiol; 1988; 40(4):213-8. PubMed ID: 3073282
    [No Abstract]   [Full Text] [Related]  

  • 33. The first detection of CTX-M-14 extended-spectrum beta-lactamase among diverse beta-lactamase-producing Proteus mirabilis clinical isolates.
    Yong D; Lim YS; Roh KH; Choi YS; Park DY; Yum JH; Kim JM; Lee K; Chong Y
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):237-9. PubMed ID: 16427241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic resistance pattern among biofilm producing and non producing Proteus strains isolated from hospitalized patients; matter of hospital hygiene and antimicrobial stewardship.
    Shikh-Bardsiri H; Shakibaie MR
    Pak J Biol Sci; 2013 Nov; 16(22):1496-502. PubMed ID: 24511691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The incidence of extended spectrum beta-lactamases in Proteus mirabilis strains isolated in 2007-2009].
    Kwiecińska-Piróg J; Bogiel T; Gospodarek E
    Przegl Epidemiol; 2010; 64(3):395-8. PubMed ID: 20976952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sensitivity to beta-lactam and aminoglycoside antibiotics of clinical Proteus strains as dependent upon on their species classification and the source of their isolation].
    Shvidenko IG
    Antibiot Med Biotekhnol; 1987 Nov; 32(11):850-5. PubMed ID: 3326520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotyping and the Dienes reaction on Proteus mirabilis from hospital infections.
    De Louvois J
    J Clin Pathol; 1969 May; 22(3):263-8. PubMed ID: 4891480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serious nosocomial infection caused by Morganella morganii and Proteus mirabilis in a cardiac surgery unit.
    Williams EW; Hawkey PM; Penner JL; Senior BW; Barton LJ
    J Clin Microbiol; 1983 Jul; 18(1):5-9. PubMed ID: 6350354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of spontaneously agglutinating Proteus mirabilis strains from bacteriuric patients.
    Krajewska-Pietrasik D; Larsson P; Zych K; Wlodarczyk J; Gromska W
    APMIS; 1991 Oct; 99(10):956-60. PubMed ID: 1930968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.